Email Facebook Twitter

PHARMA: Heat Biologics - a 'potentially transformative' lung cancer treatment, Phase II data Q3 2018 Watch here

Looking for big risk, big reward investing? See our exclusive Pharma video series from 'Biotech and Money'

Regulatory News

Lyxor EURO STOXX 300 (DR) - UCITS ETF Monthly Hedged C-GBP Net Asset Value(s)

Fri, 10th Nov 2017 16:55

10-Nov-2017 / 16:55 GMT
Dissemination of a Regulatory Announcement, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.

Net Asset Value(s)

FUND: Lyxor EURO STOXX 300 (DR) - UCITS ETF Monthly Hedged C-GBP

DEALING DATE: 09-Nov-2017

NAV PER SAHRE: GBP: 119.9921



ISIN: LU1237272825

(c) EQS Group Limited

Back to Regulatory News

Share Price, Share Chat, Stock Market news at
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at

Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.